CIK 0001571934
- Non-accelerated filer
- Smaller reporting company
TAO Synergies Inc.
Sign in to watch- Ticker
- TAOX
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461585656
- Phone
- +1 973-242-0005
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Synaptogenix, Inc., NEUROTROPE BIOSCIENCE, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-16 | Alkon Daniel L. President and CSO | Sale | −19,688 | $1.17 | $23K | 35,546 |
| 2022-11-15 | Alkon Daniel L. | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2022-11-15 | Alkon Daniel L. | Grant or award · Stock Option (Right to Buy) | +112,000 | 112,000 | ||
| 2021-07-13 | Alkon Daniel L. President and CSO | Grant or award | +43,750 | 55,234 | ||
| 2021-07-13 | Alkon Daniel L. | Grant or award | +80,000 | 91,484 | ||
| 2021-06-14 | Alkon Daniel L. Chief Scientific Officer | Purchase | +10,000 | $8.26 | $83K | 11,484 |
Page 1 of 1 · 6 trades